FDA drug class
Mast Cell Stabilizers list
Every FDA-approved prescription drug the FDA NDC directory tags with the Mast Cell Stabilizer [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
The FDA NDC directory lists 2 single-ingredient drugs in this class: cromolyn, olopatadine. Another 1 combination product include one of them.
Run it in Rivvi
Map Gastrocrom and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Mast Cell Stabilizers (3)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Cromolyn | Gastrocrom | Single ingredient | 9 | Not controlled |
| Olopatadine | None listed | Single ingredient | 7 | Not controlled |
| Olopatadine and mometasone furoate | Ryaltris | Combination | 2 | Not controlled |
FDA established pharmacologic class: Mast Cell Stabilizer [EPC].
Questions
What drugs are Mast Cell Stabilizers?
The FDA NDC directory lists 2 single-ingredient drugs in this class: cromolyn, olopatadine. Another 1 combination product include one of them.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.